SEC Form 4 · accession 0000899243-16-035811
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ted W Love
Officer — CEO and President · Director
Period of report
Jul 1, 2016
Accepted (ET)
Dec 16, 2016 · 6:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2016 | D | 24,821 | $3.40 | D | 1,139,815 | D | |
| Common Stock | holding | — | — | — | 2,500 | I | By daughter | |
| Common Stock | holding | — | — | — | 2,500 | I | By daughter |
Table II — derivative securities
No Table II lines on this filing.